Dariusz Lange Selected Research

Follicular Adenocarcinoma

6/2019	Spectroscopic identification of benign (follicular adenoma) and cancerous lesions (follicular thyroid carcinoma) in thyroid tissues.
11/2018	Spectroscopic analysis of normal and neoplastic (WI-FTC) thyroid tissue.
11/2016	Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
1/2015	A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.
5/2014	Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
10/2013	Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.
1/2005	Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
1/2004	Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
1/2004	Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
1/2004	Analysis of P161NK4A protein expression in follicular thyroid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dariusz Lange Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 01/2004
12	Adenoma (Adenomas) 11/2018 - 01/2004
11	Carcinoma (Carcinomatosis) 01/2015 - 01/2004
10	Follicular Adenocarcinoma 06/2019 - 01/2004
9	Thyroid Neoplasms (Thyroid Cancer) 06/2019 - 01/2004
8	Melanoma (Melanoma, Malignant) 04/2018 - 10/2009
6	Papillary Thyroid Cancer 01/2017 - 05/2005
5	Breast Neoplasms (Breast Cancer) 07/2020 - 09/2014
5	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2015 - 01/2010
5	Nodular Goiter 04/2009 - 01/2004
4	Neoplasm Metastasis (Metastasis) 11/2018 - 12/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017 - 01/2008
3	follicular Thyroid cancer 06/2017 - 01/2013
2	Nevus (Nevi) 04/2018 - 02/2013
2	Lymphatic Metastasis 10/2016 - 02/2013
2	Laryngeal Neoplasms (Laryngeal Cancer) 09/2015 - 10/2009
2	Carcinogenesis 05/2014 - 01/2014
2	Polyps 04/2013 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 02/2013 - 05/2011
2	Cardiomyopathies (Cardiomyopathy) 02/2013 - 04/2012
2	Heart Failure 04/2012 - 05/2011
2	Papillomavirus Infections 05/2011 - 01/2010
2	Thyroid Diseases (Thyroid Disease) 04/2009 - 02/2005
2	Papillary Carcinoma 04/2009 - 10/2005
2	Adenocarcinoma 01/2009 - 03/2006
2	Goiter 07/2006 - 10/2005
1	Papilloma (Papillomatosis) 09/2017
1	Carcinoid Tumor (Carcinoid) 01/2017
1	Triple Negative Breast Neoplasms 01/2016
1	Paraganglioma (Paragangliomas) 04/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2014
1	Respiratory Insufficiency (Respiratory Failure) 01/2013
1	Osteosarcoma (Osteogenic Sarcoma) 01/2013
1	Metaplasia 01/2013
1	Diabetes Complications 04/2012
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2012
1	Hemorrhage 03/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2012
1	Ischemia 09/2011
1	Ventricular Tachycardia 09/2011

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 07/2020 - 01/2004
12	ParaffinIBA 04/2018 - 01/2008
9	Formaldehyde (Formol)FDA Link 04/2018 - 01/2012
8	RacivirIBA 06/2019 - 01/2004
7	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2005
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2016 - 10/2009
3	EnzymesIBA 01/2018 - 07/2010
3	MicroRNAs (MicroRNA)IBA 11/2016 - 05/2014
3	Cyclin-Dependent Kinase Inhibitor p16IBA 10/2015 - 01/2004
3	Advanced Glycation End ProductsIBA 02/2013 - 05/2011
3	OligonucleotidesIBA 10/2009 - 02/2005
2	Biological ProductsIBA 01/2019 - 01/2016
2	Hormones (Hormone)IBA 01/2018 - 01/2016
2	LipidsIBA 01/2018 - 04/2012
2	Protein Isoforms (Isoforms)IBA 12/2017 - 03/2016
2	Indicators and Reagents (Reagents)IBA 10/2016 - 01/2011
2	ChromograninsIBA 04/2015 - 01/2013
2	SynaptophysinIBA 04/2015 - 01/2013
2	Keratins (Keratin)IBA 04/2015 - 01/2013
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2015 - 01/2013
2	AntibodiesIBA 09/2014 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 02/2013 - 04/2012
2	carboxyaminoimidazole ribotide (CAIR)IBA 01/2012 - 05/2011
2	Cyclin D1IBA 01/2012 - 01/2005
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022
1	CollagenIBA 07/2020
1	CarbohydratesIBA 07/2020
1	Nucleic AcidsIBA 07/2020
1	ProteomeIBA 01/2018
1	Histone DemethylasesIBA 12/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	TrypsinIBA 07/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	AcidsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Chromogranin AIBA 01/2017
1	Histones (Histone)IBA 03/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016
1	InterferonsIBA 12/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015
1	Interferon-gamma (Interferon, gamma)IBA 12/2015
1	S100 Proteins (S 100 Protein)IBA 01/2014
1	Proline (L-Proline)FDA Link 01/2014
1	Thyroglobulin FDA Link 01/2013
1	VimentinIBA 01/2013
1	SolutionsIBA 01/2012
1	MucinsIBA 01/2012
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2012
1	factor AIBA 01/2012
1	Valine (L-Valine)FDA Link 09/2011
1	Leucine (L-Leucine)FDA Link 09/2011

Therapy/Procedure

9	Radiotherapy 09/2015 - 01/2005
3	Therapeutics 07/2020 - 01/2017
3	Transplantation 02/2013 - 05/2011
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2016
2	Neoadjuvant Therapy 01/2019 - 01/2016
1	Heterologous Transplantation (Xenotransplantation) 02/2013
1	Curettage 03/2012